Stereotaxis (NYSE:STXS) announced the publication of initial clinical results using its MAGiC robotic magnetic navigation catheter. The results, published in the Journal of Interventional Cardiac Electrophysiology, mark the first peer-reviewed literature supporting the efficacy and safety of MAGiC. MAGiC, a robotically navigated magnetic ablation catheter, performs minimally invasive cardiac radiofrequency (RF) ablation procedures. It incorporates design […]
MassDevice Cardiovascular Hub
MassDevice's Cardiovascular Hub is your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ First Look: Boston Scientific’s next-gen Faraflex PFA and mapping catheter
+ How Abbott dialed in the waveform for its Volt PFA system
+ The top 10 cardiac device stories of 2024
+ The latest AI-powered cardiology devices you need to know
Latest Cardiology News
MiRus reports positive early feasibility data for heart valve
MiRus announced new early feasibility study results supporting the use of its Siegel transcatheter aortic valve replacement (TAVR) system. Dr. Pradeep Yadav (Piedmont Heart Institute) and Dr. Raj Makkar (Cedars Sinai) presented findings in podium presentations at NY Valves. Thirty-day results came from the company’s U.S. early feasibility study (EFS). MiRus announced the start of […]
CroíValve picks up new funding from European accelerator
CroíValve announced today that it received new funding from Horizon Europe’s European Innovation Council (EIC) Accelerator Program. EIC awarded the funding as part of the EU’s Horizon Europe 2021-2027 Research and Innovation Program. It provides funding to high-potential, high-risk startups, scale-ups and subject matter experts. The competition included 959 applicants for 40 awards across 16 […]
Kardium raises $250M to support pulsed field ablation system
Kardium announced today that it raised $250 million in a new financing round to support the launch of its pulsed field ablation system. New investors, including Janus Henderson Investors, Qatar Investment Authority (QIA), MMCAP, Piper Heartland Healthcare Capital, Eventide Asset Management and Eckuity Capital, led the oversubscribed round. Existing investors, such as funds advised by […]
Carmat files for insolvency
French artificial heart developer Carmat has filed for insolvency with the Versailles Economic Affairs Court. The filing, announced yesterday, seeks to have the company placed into receivership. In addition to filing for insolvency, Carmat requested that Euronext suspend the trading of its ALCAE shares, effective June 30. Carmat had warned in a June 20 news release […]
Field Medical raises $35M Series B to support pulsed field ablation tech
Field Medical announced today that it closed a Series B funding round worth proceeds totaling $35 million. BioStar Capital and Cue Growth led the round, which had participation from existing strategic investors, too. This funding adds to a $40 million Series A brought in earlier this year and brings the Cardiff-by-the-Sea, California-based company’s total funding […]
Acutus to sell electrophysiology assets to EnChannel
EnChannel Medical announced today that it agreed to acquire the AcQMap platform assets from Acutus Medical. This deal centers around the AcQMap high-resolution imaging and mapping platform from Acutus. It also includes substantive intellectual property, quality and regulatory documentation and clinical data. With the agreement, EnChannel receives a limited number of AcQMap systems and associated […]
Teleflex completes acquisition of Biotronik’s Vascular Intervention business
Teleflex announced today that it completed its previously announced acquisition of the Biotronik Vascular Intervention (VI) business. As part of strategy shifts by both companies, Teleflex in February agreed to acquire substantially all of the Biotronik VI unit. The acquisition adds a broad portfolio of therapeutic products to the Wayne, Pennsylvania-based company’s interventional access products. […]
InterShunt enrolls first patient in heart failure treatment study
InterShunt Technologies announced today that it has begun an early feasibility study of its device for reducing symptoms of heart failure. Dr. Sitaramesh Emani and the Structural Heart Intervention Team at The Christ Hospital Health Network in Cincinnati, performed the first procedure utilizing the technology. The study focuses on patients with heart failure with reduced ejection […]
STENTiT enrolls first patient in trial of regenerative stent system
STENTiT has implanted its Resorbable Fibrillated Scaffold in the first patient enrolled in the VITAL-IT 1 study evaluating the device for chronic limb-threatening ischemia (CLTI) below the knee. The prospective, non-randomized feasibility study will enroll up to 10 patients at the Medical University of Graz in Austria and follow them for 24 months. Investigators used […]
Foldax presents positive polymer heart valve data
Foldax today announced one-year results from a clinical trial of its Tria polymer mitral heart valve offering. In a trial based in India, the mitral valve demonstrated a good safety profile and sustained hemodynamic performance. Investigators reported a statistically significant improvement in patient quality of life. “These results validate our strategy of taking heart valve therapy […]
